N/A
N=2,765
A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)
Allergic Rhinoconjunctivitis
Bottom Line
View on ClinicalTrials.gov: NCT01535118 ↗Enrolled (actual)
2,765
Serious AEs
—
Results posted
Jan 2014
Primary outcome: Primary: Percentage of Participants Who Experienced Daily Symptoms Due to Allergic Rhinoconjunctivitis (ARC) — 41; 39; 38; 29 percentage of participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult · 5+ yrs
- Sex
- All
- Sponsor
- ALK-Abelló A/S
- Primary completion
- May 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Who Experienced Daily Symptoms Due to Allergic Rhinoconjunctivitis (ARC) |
41; 39; 38; 29; 26; 12 | — |
| PRIMARY Percentage of Participants Who Experienced Work or School Absence Due to ARC in the Past 12 Months |
35 | — |
| PRIMARY Percentage of Participants Who Used Medication to Treat ARC in the Past 12 Months |
58; 81 | — |
| PRIMARY Percentage of Participants Who Received Immunotherapy to Treat ARC |
21; 2 | — |
| PRIMARY Percentage of Participants Who Received Allergy Shots and Required Supplemental Prescription Allergy Medication |
67 | — |
| SECONDARY Percentage of Participants Who Received Allergy Shots and Had a Co-morbid Condition of Asthma |
31 | — |
Summary
This study will gather information on allergic rhinoconjunctivitis from surveys completed by adults and children.
Eligibility Criteria
Inclusion Criteria
- Diagnosed with hay fever, rhinitis or nasal and/or eye allergies and display symptoms of sneezing, itching, watery eyes, nasal congestion, or other nasal or eye allergy symptoms over the past 12 months OR take any medication for their hay fever, rhinitis, nasal or eye allergies
- 5 years of age or older
- Have a telephone
Exclusion Criteria
- If less than 18 years old and there is no adult available that is knowledgeable about the participant's health
Data sourced from ClinicalTrials.gov (NCT01535118). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.